Menu
 

Search abstracts


Delivery of glycoside hydrolases to combat bacterial biofilms

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Poster
  • By: THORN, Chelsea (University of South Australia, School of Pharmacy and Medical Science)
  • Co-author(s): Chelsea Renee Thorn: School of Pharmacy and Medical Science and ARC Centre for Excellence in Bio-Nano Science and Technology, University of South Australia, Adelaide, Australia
    Clive A. Prestidge: School of Pharmacy and Medical Science and ARC Centre for Excellence in Bio-Nano Science and Technology, University of South Australia, Adelaide, Australia
    Ben J. Boyd: Drug Delivery Disposition and Dynamics, and ARC Centre for Excellence in Bio-Nano Science and Technology, Monash Institute of Pharmaceutical Sciences, Melbourne, Australia
    Nicky Thomas: School of Pharmacy and Medical Science and ARC Centre for Excellence in Bio-Nano Science and Technology, University of South Australia, Adelaide, Australia
  • Abstract:

    Background

    The morbidity resulting from chronic wounds is dramatically increasing with 90% of wounds being related to antibiotic-tolerant biofilm infections [1]. Glycoside hydrolases (e.g. alginate lyase), are potent, novel therapies to disrupt biofilms, and increase the susceptibility of residing bacteria to antibiotics [3]. However, the clinical..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 13 May 2019

FIP Congresses